首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

2126372

家庭診斷市場－策略分析與預測（2026-2035）

Home Diagnostics Market - Strategic Insights and Forecasts (2026-2035)

出版日期: 2026年08月06日 | 出版商:

Knowledge Sourcing Intelligence | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

預計家庭診斷市場將從 2026 年的 79 億美元成長到 2035 年的 206.3 億美元，複合年成長率為 11.3%。

受以患者為中心的照護模式轉移、自我檢測和遠距醫療的推動，家庭診斷市場正經歷重大變革。這一市場演變的特點是，人們日益認知到便捷易用的診斷解決方案能夠幫助個人主動管理自身健康，從而降低醫療成本並改善疾病管理效果。數位健康技術、人工智慧、生物感測器和智慧型手機連接醫療設備的融合，催生了先進且方便用戶使用的家庭診斷解決方案，使其能夠在傳統臨床環境之外提供精準的檢測結果。隨著慢性病盛行率的持續上升，醫療服務提供者也尋求更有效率的服務模式，全球醫療系統正在積極採用遠端醫療和遠端患者監護。隨著市場對數位診斷、基因檢測和連線健診健康平台的巨額投資，家庭診斷正逐漸成為現代預防醫學和個人化醫療的基石。

市場促進因素

糖尿病和其他需要持續監測的慢性疾病盛行率不斷上升，是推動家庭診斷市場發展的主要動力。隨著慢性疾病負擔的加重，人們對便捷易用的監測解決方案的需求持續成長，這些方案能夠幫助患者在醫療機構之外追蹤自身健康狀況。醫療系統正在擴展遠端患者監護項目，以改善疾病管理並降低醫療成本。這種需求推動了多種疾病類別對家庭診斷產品的需求，並持續提升了家庭診斷的使用率。此外，消費者對便利居家醫療解決方案的日益偏好也進一步加速了市場擴張。人們越來越傾向於選擇無需前往醫療機構且能快速獲得結果的自我檢測方式。這一趨勢在減少醫療服務使用的同時，提高了患者的參與度和疾病意識提升。診斷設備製造商正在擴展其家庭產品線，以滿足不斷成長的消費者需求。遠端醫療和遠端患者監護的日益普及推動了對連網家庭診斷設備的需求。遠端醫療的擴展催生了對能夠支援遠距臨床評估和患者管理的診斷工具的需求。數位健康平台需要與家庭診斷設備無縫整合，才能實現全面的遠距遠端醫療服務。技術開發人員正在增強連接性和數據整合能力，以支援虛擬醫療模式。生物感測器、數位診斷和連線健診設備的技術進步正在提高家庭檢測的準確性和易用性。分子診斷、生物感測器和人工智慧驅動的結果解讀方面的持續創新正在擴展家庭診斷平台的功能。這些改進有助於家庭診斷平台在臨床環境中得到更廣泛的應用，並增強消費者的信心。

市場限制因素

對診斷準確性和使用者對結果解讀的擔憂限制了家用診斷產品的普及和臨床接受度。使用者操作和環境因素造成的差異會影響測試效能和結果的可靠性。部分家用診斷產品的保險覆蓋範圍有限，導致其價格難以負擔，從而降低了消費者的接受獎勵。不同地區保險政策的不統一也是消費者使用該產品的一大障礙。嚴格的自測設備法規核准要求增加了研發時間和成本。對市售診斷產品嚴格的證據要求也構成了市場准入障礙。與連網診斷平台相關的資料隱私和網路安全問題也帶來了新的管治要求。先進的家用監測技術高成本，限制了其在價格敏感型市場的普及。

分析：按產品
- 檢測套組
- 監控設備
- 測量儀器和領導者
- 行動應用和軟體
分析：按技術
- 橫向流動化驗
- 免疫測量
- 分子診斷
- 基於生物感測器的診斷
- 數位診斷
分析：按測試類型
- 血糖值測試
- 妊娠和不孕症檢查
- 傳染病檢查
- 膽固醇檢測
- 尿液檢查
- 大便潛血試驗
- 基因檢測
- 其他居家診斷測試
分析：按分銷管道
- 零售藥房
- 醫院藥房
- 網路藥房
- DTC頻道

第9章：全球家庭診斷市場：細分市場分析

依產品
- 檢測套組
- 監控設備
- 測量儀器和領導者
- 軟體
按測試類型
- 血糖值測試
- 妊娠和不孕症檢查
- 傳染病檢查
- 膽固醇檢測
- 尿液檢查
- 基因檢測
- 其他測試
依檢體類型
- 血
- 尿
- 唾液
- 航班
- 鼻拭子
- 其他類型的檢體
最終用戶
- 成人
- 老年人
- 兒童患者群體

第10章：全球家庭診斷市場：區域分析

北美洲
歐洲
亞太地區
南美洲
中東和非洲

第11章：全球家庭診斷市場：國別分析

美國
加拿大
德國
英國
法國
義大利
西班牙
日本
中國
印度
韓國
澳洲
巴西
墨西哥
沙烏地阿拉伯
南非

第12章競爭格局

市佔率分析
策略趨勢
企業合併、合作與聯盟
新產品發布

第13章：公司簡介

Abbott Laboratories
F. Hoffmann-La Roche Ltd.
Becton, Dickinson and Company
Siemens Healthineers AG
QuidelOrtho Corporation
OraSure Technologies, Inc.
Everlywell, Inc.
LetsGetChecked
bioMerieux
ACON Laboratories, Inc.
EKF Diagnostics Holdings plc
Trinity Biotech plc
SD Biosensor, Inc.
Access Bio, Inc.
iHealth Labs Inc.

第14章：全球家庭診斷市場：商業預測分析

第15章投資與資金籌措分析

創業投資趨勢
政府資金
研發投資

第16章：未來展望

主要成長機遇
未來產業趨勢

簡介目錄

Product Code: KSI-009084

The Home Diagnostics Market is set to reach USD 20.63 billion in 2035, growing at a CAGR of 11.3 % from USD 7.9 billion in 2026.

The home diagnostics market is undergoing significant transformation driven by the paradigm shift toward patient-centric healthcare, self-testing, and remote disease management. The market's evolution is characterized by the growing recognition that convenient, accessible diagnostic solutions empower individuals to take proactive control of their health, reducing healthcare costs and improving disease management outcomes. The convergence of digital health technologies, artificial intelligence, biosensors, and smartphone-connected medical devices is enabling sophisticated, user-friendly home diagnostic solutions that deliver accurate results outside traditional clinical settings. Healthcare systems worldwide are embracing telemedicine and remote patient monitoring as chronic disease prevalence continues to rise and healthcare providers seek more efficient care delivery models. The market is witnessing significant investment in digital diagnostics, genetic testing, and connected health platforms, positioning home diagnostics as a cornerstone of modern preventive healthcare and personalized medicine.

Market Drivers

The growing prevalence of diabetes and other chronic diseases requiring continuous monitoring represents the primary driver for the home diagnostics market. Increasing chronic disease burden creates sustained demand for convenient, accessible monitoring solutions that enable patients to track their health status outside clinical settings. Healthcare systems are expanding remote patient monitoring programs to improve disease management and reduce healthcare costs. This requirement strengthens demand for home diagnostic products across multiple disease categories, resulting in sustained growth in home diagnostic utilization. The increasing consumer preference for convenient home-based healthcare solutions is further accelerating market expansion. Individuals increasingly seek self-testing options that provide rapid results without requiring clinic visits. This trend reduces healthcare utilization while improving patient engagement and disease awareness. Diagnostic manufacturers are expanding home-use product portfolios to capture growing consumer demand. The rising adoption of telemedicine and remote patient monitoring is driving demand for connected home diagnostic devices. Telehealth expansion creates demand for diagnostic tools capable of supporting remote clinical assessments and patient management. Digital health platforms require seamless integration with home diagnostic devices to enable comprehensive remote care delivery. Technology developers are strengthening connectivity and data integration capabilities to support virtual healthcare models. Technological advancements in biosensors, digital diagnostics, and connected healthcare devices are improving home testing accuracy and usability. Continuous innovation in molecular diagnostics, biosensors, and AI-enabled interpretation is expanding the capabilities of home diagnostic platforms. These improvements support broader clinical adoption and increased consumer confidence.

Market Restraints

Concerns regarding diagnostic accuracy and user interpretation limit adoption and clinical acceptance of home diagnostic products. Variability in user technique and environmental factors can affect test performance and result reliability. Limited reimbursement coverage for several home diagnostic products reduces affordability and adoption incentives. Inconsistent coverage policies across regions create barriers to consumer access. Stringent regulatory approval requirements for self-testing devices increase development timelines and costs. The rigorous evidence requirements for over-the-counter diagnostic products create barriers to market entry. Data privacy and cybersecurity concerns associated with connected diagnostic platforms create additional governance requirements. High cost of advanced home monitoring technologies limits adoption in price-sensitive markets.

Technology and Product Insights

The technology landscape is characterized by the growing importance of digital health integration, connected devices, and user-friendly platforms. Lateral flow assays remain widely adopted due to their affordability and ease of use. Immunoassays continue supporting a broad range of home diagnostic applications. Molecular diagnostics are expanding for infectious disease testing and genetic applications. Biosensor-based diagnostics are gaining adoption for glucose monitoring and other chronic disease management applications. Digital diagnostics represent the fastest-growing segment, driven by AI-enabled interpretation and smartphone connectivity. The segment analysis reveals that test kits account for the largest share due to widespread use in pregnancy testing, infectious disease detection, cholesterol testing, and self-screening applications. Monitoring devices continue to experience strong growth driven by increasing adoption of blood glucose monitors, blood pressure monitors, and connected wearable devices. Software platforms are expanding rapidly with integration of cloud connectivity, AI, and mobile health applications. Blood glucose testing dominates the market because of the large global diabetic population requiring continuous monitoring. Infectious disease testing is experiencing rapid expansion due to increasing availability of rapid home-based diagnostic kits. Genetic testing represents one of the fastest-growing segments, driven by increasing consumer interest in personalized health information. Blood remains the primary sample type owing to its widespread use in glucose monitoring and chronic disease diagnostics. Adults represent the largest end-user segment, with geriatric population expanding due to aging demographics. Retail pharmacies represent the leading distribution channel, with online pharmacies and direct-to-consumer channels experiencing rapid growth. The integration of digital health is becoming increasingly important as home diagnostics are integrated with AI, telehealth platforms, and electronic health records.

Competitive and Strategic Outlook

The competitive landscape features established diagnostics and healthcare companies alongside specialized direct-to-consumer, digital health, and home testing providers. Abbott is a global leader through its blood glucose monitoring systems, rapid diagnostic tests, and connected diabetes care solutions, continuing to expand digital health capabilities and remote patient monitoring technologies. Roche develops advanced home diagnostic technologies, molecular testing solutions, and digital healthcare platforms that support personalized medicine and chronic disease management. BD provides home healthcare devices, specimen collection systems, diagnostic technologies, and connected healthcare solutions that enhance decentralized patient testing and disease monitoring. Siemens Healthineers offers digital diagnostic solutions, remote monitoring technologies, and connected healthcare platforms that improve home-based patient care and clinical decision-making. QuidelOrtho specializes in rapid home diagnostic testing for infectious diseases using advanced antigen and molecular diagnostic technologies. OraSure develops rapid infectious disease diagnostics, oral fluid collection technologies, and home-based testing solutions with strong emphasis on public health applications. Everlywell provides direct-to-consumer home diagnostic testing services covering wellness, hormone health, food sensitivity, sexual health, and chronic disease screening. LetsGetChecked offers comprehensive home health testing services integrated with laboratory analysis, physician consultations, and digital health reporting. Companies are pursuing product portfolio expansion through innovation in digital diagnostics, genetic testing, and AI-enabled interpretation platforms. Strategic collaborations between diagnostic manufacturers, digital health companies, and telemedicine providers are increasing, driven by the need for integrated home care solutions. Recent key developments include Abbott expanding its connected diabetes care ecosystem with enhanced digital integration for remote patient monitoring. Roche introduced next-generation home molecular diagnostic solutions supporting decentralized healthcare. Everlywell expanded its direct-to-consumer testing portfolio with additional preventive health screening services. Siemens Healthineers strengthened its digital health platform through enhanced remote diagnostic connectivity.

Short Conclusion

The home diagnostics market is positioned for sustained growth driven by the convergence of chronic disease burden, consumer preference for self-testing, and technological innovation. The transition from clinic-based testing toward integrated, connected home diagnostic ecosystems represents a fundamental shift in healthcare delivery. While challenges related to accuracy concerns, reimbursement limitations, and regulatory requirements persist, strategic investments in technology, digital integration, and consumer engagement are creating durable competitive advantages for market leaders. The long-term market outlook remains positive, with home diagnostics evolving into a cornerstone of modern preventive healthcare, supporting chronic disease management, early detection, and improved patient outcomes across global healthcare systems.

Key Benefits of this Report

Insightful Analysis: Detailed market insights across regions, customer segments, policies, socio-economic factors, consumer preferences, and industry verticals.
Competitive Landscape: Understand strategic moves by key players to identify optimal market entry approaches.
Market Drivers and Future Trends: Assess major growth forces and emerging developments shaping the market.
Actionable Recommendations: Support strategic decisions to unlock new revenue streams.
Caters to a Wide Audience: Suitable for startups, research institutions, consultants, SMEs, and large enterprises.

What Businesses Use Our Reports For

Industry and market insights, opportunity assessment, product demand forecasting, market entry strategy, geographical expansion, capital investment decisions, regulatory analysis, new product development, and competitive intelligence.

Report Coverage

Historical data from 2021 to 2024, Base year 2025, and Forecast years from 2026 to 2035
Growth opportunities, challenges, supply chain outlook, regulatory framework, and trend analysis
Competitive positioning, strategies, and market share evaluation, and trade analysis
Revenue growth and forecast assessment across segments and regions
Company profiling including strategies, products, financials, and key developments

1. Executive Summary

1.1 Market Snapshot
1.2 Key Findings
1.3 Analyst Insights
1.4 Strategic Recommendations

2. Research Methodology

2.1 Research Design
2.2 Data Collection Methodology
2.3 Market Size Estimation
2.4 Forecasting Model
2.5 Assumptions & Limitations

3. Global Home Diagnostics Market Overview, Size & Forecast

3.1 Market Definition & Scope
3.2 Industry Overview
3.3 Industry Evolution
3.4 Key Market Trends
3.5 Historical Market Size Analysis (2021-2025)
3.6 Market Forecast (2026-2035)
3.7 Home Testing Adoption Analysis
3.8 Consumer Testing Volume Analysis
3.9 Home Diagnostics Workflow Analysis
3.10 Role of Home Diagnostics in Consumer-Centered Healthcare

4. Market Dynamics

4.1 Market Drivers
4.2 Market Restraints
4.3 Market Opportunities
4.4 Market Challenges

5. Industry Landscape

5.1 Industry Value Chain Analysis
5.2 Pricing Analysis
5.3 Reimbursement Landscape

6. Innovation Landscape

6.1 Emerging Technologies
6.2 Product Innovation
6.3 Smartphone-Connected Home Diagnostics
6.4 Artificial Intelligence and Digital Health Integration
6.5 Wearable-Enabled Home Testing
6.6 At-Home Molecular Diagnostics
6.7 Technology Roadmap

7. Regulatory Landscape

7.1 Regulatory Framework
7.2 Approval Pathways
7.3 Compliance Requirements

8. Global Home Diagnostics Market Landscape Analysis

8.1 Analysis by Product
- 8.1.1 Test Kits
- 8.1.2 Monitoring Devices
- 8.1.3 Instruments & Readers
- 8.1.4 Mobile Applications & Software
8.2 Analysis by Technology
- 8.2.1 Lateral Flow Assays
- 8.2.2 Immunoassays
- 8.2.3 Molecular Diagnostics
- 8.2.4 Biosensor-Based Diagnostics
- 8.2.5 Digital Diagnostics
8.3 Analysis by Test Type
- 8.3.1 Blood Glucose Testing
- 8.3.2 Pregnancy & Fertility Testing
- 8.3.3 Infectious Disease Testing
- 8.3.4 Cholesterol Testing
- 8.3.5 Urinalysis Testing
- 8.3.6 Fecal Occult Blood Testing
- 8.3.7 Genetic Testing
- 8.3.8 Other Home Diagnostic Tests
8.4 Analysis by Distribution Channel
- 8.4.1 Retail Pharmacies
- 8.4.2 Hospital Pharmacies
- 8.4.3 Online Pharmacies
- 8.4.4 Direct-to-Consumer Channels

9. Global Home Diagnostics Market Segment Analysis (2021-2035)

9.1 By Product
- 9.1.1 Test Kits
- 9.1.2 Monitoring Devices
- 9.1.3 Instruments & Readers
- 9.1.4 Software
9.2 By Test Type
- 9.2.1 Blood Glucose Testing
- 9.2.2 Pregnancy & Fertility Testing
- 9.2.3 Infectious Disease Testing
- 9.2.4 Cholesterol Testing
- 9.2.5 Urinalysis Testing
- 9.2.6 Genetic Testing
- 9.2.7 Other Tests
9.3 By Sample Type
- 9.3.1 Blood
- 9.3.2 Urine
- 9.3.3 Saliva
- 9.3.4 Stool
- 9.3.5 Nasal Swab
- 9.3.6 Other Sample Types
9.4 By End User
- 9.4.1 Adults
- 9.4.2 Geriatric Population
- 9.4.3 Pediatric Population

10. Global Home Diagnostics Market Geographical Analysis (2021-2035)

10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 South America
10.5 Middle East & Africa

11. Global Home Diagnostics Market Country Analysis (2021-2035)

11.1 United States
11.2 Canada
11.3 Germany
11.4 United Kingdom
11.5 France
11.6 Italy
11.7 Spain
11.8 Japan
11.9 China
11.10 India
11.11 South Korea
11.12 Australia
11.13 Brazil
11.14 Mexico
11.15 Saudi Arabia
11.16 South Africa

12. Competitive Landscape

12.1 Market Share Analysis
12.2 Strategic Developments
12.3 Mergers & Acquisitions, Partnerships & Collaborations
12.4 Product Launches

13. Company Profiles

13.1 Abbott Laboratories
- 13.1.1 Company Overview
- 13.1.2 Financials
- 13.1.3 Product Portfolio
- 13.1.4 Recent Developments
13.2 F. Hoffmann-La Roche Ltd.
- 13.2.1 Company Overview
- 13.2.2 Financials
- 13.2.3 Product Portfolio
- 13.2.4 Recent Developments
13.3 Becton, Dickinson and Company
- 13.3.1 Company Overview
- 13.3.2 Financials
- 13.3.3 Product Portfolio
- 13.3.4 Recent Developments
13.4 Siemens Healthineers AG
- 13.4.1 Company Overview
- 13.4.2 Financials
- 13.4.3 Product Portfolio
- 13.4.4 Recent Developments
13.5 QuidelOrtho Corporation
- 13.5.1 Company Overview
- 13.5.2 Financials
- 13.5.3 Product Portfolio
- 13.5.4 Recent Developments
13.6 OraSure Technologies, Inc.
- 13.6.1 Company Overview
- 13.6.2 Financials
- 13.6.3 Product Portfolio
- 13.6.4 Recent Developments
13.7 Everlywell, Inc.
- 13.7.1 Company Overview
- 13.7.2 Financials
- 13.7.3 Product Portfolio
- 13.7.4 Recent Developments
13.8 LetsGetChecked
- 13.8.1 Company Overview
- 13.8.2 Financials
- 13.8.3 Product Portfolio
- 13.8.4 Recent Developments
13.9 bioMerieux
- 13.9.1 Company Overview
- 13.9.2 Financials
- 13.9.3 Product Portfolio
- 13.9.4 Recent Developments
13.10 ACON Laboratories, Inc.
- 13.10.1 Company Overview
- 13.10.2 Financials
- 13.10.3 Product Portfolio
- 13.10.4 Recent Developments
13.11 EKF Diagnostics Holdings plc
- 13.11.1 Company Overview
- 13.11.2 Financials
- 13.11.3 Product Portfolio
- 13.11.4 Recent Developments
13.12 Trinity Biotech plc
- 13.12.1 Company Overview
- 13.12.2 Financials
- 13.12.3 Product Portfolio
- 13.12.4 Recent Developments
13.13 SD Biosensor, Inc.
- 13.13.1 Company Overview
- 13.13.2 Financials
- 13.13.3 Product Portfolio
- 13.13.4 Recent Developments
13.14 Access Bio, Inc.
- 13.14.1 Company Overview
- 13.14.2 Financials
- 13.14.3 Product Portfolio
- 13.14.4 Recent Developments
13.15 iHealth Labs Inc.
- 13.15.1 Company Overview
- 13.15.2 Financials
- 13.15.3 Product Portfolio
- 13.15.4 Recent Developments

14. Global Home Diagnostics Market Commercial Forecast Analysis

14.1 Blood Glucose Monitoring Products
14.2 Pregnancy & Fertility Test Kits
14.3 Infectious Disease Home Test Kits
14.4 Cholesterol Testing Kits
14.5 Urinalysis Test Kits
14.6 Genetic Home Testing Kits
14.7 Digital Home Diagnostic Devices
14.8 Home Diagnostic Consumables

15. Investment & Funding Analysis

15.1 Venture Capital Trends
15.2 Government Funding
15.3 R&D Investments

16. Future Outlook

16.1 Key Growth Opportunities
16.2 Future Industry Trends

02-2729-4219

+886-2-2729-4219

License/價格

相關商品

家庭診斷市場：策略與趨勢—按應用、通路、技術和國家預測—市場分析與管理指南及人工智慧 (AI) 影響（2026-2030 年）

家庭診斷檢測解決方案市場：策略洞察與預測（2026-2031 年）

日本家用診斷檢測市場規模、佔有率、趨勢及預測（按檢測類型、形式、通路和地區分類，2026-2034年）

FAQ